The long and complex process that seed genetics companies typically face as they work to shepherd crop biotech traits through the U.S. regulatory approval is delaying American farmers’ ability to obtain seeds they need to battle weeds and insects, according to officials with seed genetics companies and a biotech trade group. And, they said, the U.S. regulatory process could be putting U.S. agriculture at a competitive disadvantage ...